Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
129
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Amantadine and cognitive flexibility: decision making in Parkinson’s patients with severe pathological gambling and other impulse control disorders

Nicoletta Cera1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;2 ITAB-Institute for Advanced Biomedical Technologies, Chieti, ItalyCorrespondence[email protected]
,
Stefania Bifolchetti1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;3 Aging Research Centre, Ce.S.I., “G. d’Annunzio” University Foundation, Chieti, Italy
,
Giovanni Martinotti1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;2 ITAB-Institute for Advanced Biomedical Technologies, Chieti, Italy
,
Francesco Gambi1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;2 ITAB-Institute for Advanced Biomedical Technologies, Chieti, Italy
,
Gianna Sepede1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;2 ITAB-Institute for Advanced Biomedical Technologies, Chieti, Italy
,
Marco Onofrj1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;3 Aging Research Centre, Ce.S.I., “G. d’Annunzio” University Foundation, Chieti, Italy
,
Massimo Di Giannantonio1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy
&
Astrid Thomas1 Department of Neuroscience and Imaging, “G. d’Annunzio” University, Chieti, Italy;3 Aging Research Centre, Ce.S.I., “G. d’Annunzio” University Foundation, Chieti, Italy
 show all
Pages 1093-1101 | Published online: 17 Jun 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Thomas Müller, Wilfried Kuhn & Jan-Dominique Möhr. (2019) Evaluating ADS5102 (amantadine) for the treatment of Parkinson’s disease patients with dyskinesia. Expert Opinion on Pharmacotherapy 20:10, pages 1181-1187.
Read now
Mei Yu, Yuan Zhang, Xiaoyu Chen & Tao Zhang. (2016) Antidepressant-like effects and possible mechanisms of amantadine on cognitive and synaptic deficits in a rat model of chronic stress. Stress 19:1, pages 104-113.
Read now

Articles from other publishers (16)

Luis E. Zayas & Ruth H. Walker. (2022) Amantadine Treatment for Hyperkinetic Movements in Chorea‐Acanthocytosis. Movement Disorders Clinical Practice 10:2, pages 346-347.
Crossref
Yajing Wang, Jie Liu, Guoqiang Song, Yingcong Yu & Xianfeng Huang. (2022) Design and Synthesis of PDE2A Inhibitors for the Treatment of Parkinson's Disease. ChemistrySelect 7:36.
Crossref
Olivier Rascol, Margherita Fabbri & Werner Poewe. (2021) Amantadine in the treatment of Parkinson's disease and other movement disorders. The Lancet Neurology 20:12, pages 1048-1056.
Crossref
Jun-Fang Zhang, Xi-Xi Wang, Ya Feng, Robert Fekete, Joseph Jankovic & Yun-Cheng Wu. (2021) Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Frontiers in Psychiatry 12.
Crossref
Pedro J. Garcia-Ruiz. (2018) Impulse Control Disorders and Dopamine-Related Creativity: Pathogenesis and Mechanism, Short Review, and Hypothesis. Frontiers in Neurology 9.
Crossref
Alice Martini, Denise Dal Lago, Nicola M. J. Edelstyn, James A. Grange & Stefano Tamburin. (2018) Impulse Control Disorder in Parkinson's Disease: A Meta-Analysis of Cognitive, Affective, and Motivational Correlates. Frontiers in Neurology 9.
Crossref
Tomoya Kon, Tatsuya Ueno, Rie Haga & Masahiko Tomiyama. (2018) The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study. Brain and Behavior 8:8, pages e01036.
Crossref
Andrew Dawson, Nadeeka N. Dissanayaka, Andrew Evans, Antonio Verdejo-Garcia, Trevor T.J. Chong, Giuseppe Frazzitta, Davide Ferrazzoli, Paola Ortelli, Murat Yücel & Adrian Carter. (2018) Neurocognitive correlates of medication-induced addictive behaviours in Parkinson's disease: A systematic review. European Neuropsychopharmacology 28:5, pages 561-578.
Crossref
Sam-Wook Choi, Young-Chul Shin, Dai-Jin Kim, Jung-Seok Choi, Seohee Kim, Seung-Hyun Kim & HyunChul Youn. (2017) Treatment modalities for patients with gambling disorder. Annals of General Psychiatry 16:1.
Crossref
Débora Mascella Krieger, Sabrina Vilanova Cardoso, Wolnei Caumo, Guilherme Valença, Daniel Weintraub & Carlos Roberto de Mello Rieder. (2017) Parkinson’s Disease Impulsive-Compulsive Disorders Questionnaire – Current Short (QUIP-CS) – Translation and validation of content of Portuguese Version. Jornal Brasileiro de Psiquiatria 66:2, pages 111-115.
Crossref
Gabriella Santangelo, Simona Raimo & Paolo Barone. (2017) The relationship between Impulse Control Disorders and cognitive dysfunctions in Parkinson’s Disease: A meta-analysis. Neuroscience & Biobehavioral Reviews 77, pages 129-147.
Crossref
V. Voon. 2017. Decision Neuroscience. Decision Neuroscience 305 314 .
Marco Onofrj, Valerio Frazzini, Laura Bonanni & Astrid Thomas. 2016. Parkinson's Disease. Parkinson's Disease 13 22 .
. 2016. Parkinson's Disease. Parkinson's Disease 1 92 .
P. Justin Rossi, Aysegul Gunduz & Michael S. Okun. (2015) The Subthalamic Nucleus, Limbic Function, and Impulse Control. Neuropsychology Review 25:4, pages 398-410.
Crossref
Mateusz Zurowski & Jonathan Darcy O’Brien. (2015) Developments in impulse control behaviours of Parkinson's disease. Current Opinion in Neurology 28:4, pages 387-392.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.